Davidson Investment Advisors Abb Vie Inc. Transaction History

Davidson Investment Advisors

$1.93 Billion
Q1 2024

A detailed history of Davidson Investment Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Davidson Investment Advisors holds 2,870 shares of ABBV stock, worth $470,220. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,870

Previous 3,095 7.27%

Holding current value

$470,220

Previous $479,000 8.98%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $35,959 - $40,972	-225 Reduced 7.27%	2,870 $522,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $98,624 - $113,580	-682 Reduced 18.06%	3,095 $493,000
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $59,888 - $71,821	-433 Reduced 10.29%	3,777 $610,000
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 2.32%	4,210 $565,000
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $19,954 - $25,369	-145 Reduced 3.25%	4,310 $660,000

Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $7,918 - $9,825	60 Added 1.37%	4,455 $722,000
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $135,361 - $171,271	-1,260 Reduced 22.28%	4,395 $595,000
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $206,096 - $233,950	-1,937 Reduced 25.51%	5,655 $610,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $2,630 - $2,930	25 Added 0.33%	7,592 $855,000
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $556,716 - $612,878	-5,442 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $438,026 - $591,382	5,442 New	5,442 $583,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $3,225 - $4,889	-50 Reduced 0.89%	5,555 $423,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $5,409 - $6,768	-75 Reduced 1.32%	5,605 $496,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $8,628 - $10,373	-137 Reduced 2.36%	5,680 $430,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $9,855 - $12,597	-150 Reduced 2.51%	5,817 $423,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $515,835 - $607,112	-6,687 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $18,450 - $22,754	-237 Reduced 3.42%	6,687 $616,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $30,229 - $33,605	-340 Reduced 4.68%	6,924 $655,000
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $28,639 - $33,887	319 Added 4.59%	7,264 $673,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $343,013 - $459,326	-3,728 Reduced 34.93%	6,945 $657,000
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $74,872 - $82,103	836 Added 8.5%	10,673 $1.03 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $6,426 - $8,208	92 Added 0.94%	9,837 $874,000
Q2 2017 Aug 11, 2017	BUY	N/A	9,745	9,745 $706,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.

Account

Davidson Investment Advisors Abb Vie Inc. Transaction History